Ambient AI platforms are designed to capture patient-clinician conversations and assist with documentation, potentially reducing time spent on administrative tasks while supporting more focused patient care. As these tools are increasingly integrated into healthcare workflows, health systems face important questions about their effects on clinician documentation burden, patient-provider communication, care quality, operational efficiency and trust.
Regenstrief Institute and Suki are collaborating to explore how independent research can help healthcare organizations better understand the impact of ambient AI technologies. The partnership will generate evidence on how these tools affect clinicians, patients and healthcare delivery, supporting informed decisions about responsible AI implementation.
Suki develops AI-powered ambient clinical intelligence solutions that assist clinicians with documentation and administrative tasks. Regenstrief is positioned to help answer critical questions about how AI technologies perform in real-world clinical environments because of their longstanding expertise in healthcare data, clinical informatics and rigorous evaluations of innovative technologies. Together, the organizations share an interest in advancing evidence-based approaches that help healthcare organizations make informed decisions about the adoption and implementation of these technologies.
“Healthcare organizations need rigorous, independent evidence to understand not only whether AI technologies work, but how they affect clinicians, patients and care delivery in real-world settings,” said Rachel Patzer, PhD, MPH, president and CEO of Regenstrief Institute. “As ambient AI continues to evolve, research and evaluation will play a critical role in ensuring these technologies are implemented responsibly and effectively.”
As ambient AI becomes more widely available to clinicians, healthcare leaders, policymakers and providers continue to seek evidence regarding implementation, outcomes, user experience and long-term impact. The partnership with the Regenstrief Institute and Suki emphasizes the importance of transparency, accountability and evidence-based decision-making.